Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: A novel type of primary hyperoxaluria

被引:29
作者
VanAcker, KJ
Eyskens, FJ
Espeel, MF
Wanders, RJA
Dekker, C
Kerckaert, IO
Roels, F
机构
[1] CHILDRENS HOSP,PROV CTR STUDY METAB DIS,DEPT PEDIAT,ANTWERP,BELGIUM
[2] STATE UNIV GHENT,DEPT ANAT EMBRYOL & HISTOL,B-9000 GHENT,BELGIUM
[3] UNIV HOSP AMSTERDAM,DEPT PEDIAT & CLIN CHEM,AMSTERDAM,NETHERLANDS
关键词
D O I
10.1038/ki.1996.494
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Considering the clinical heterogeneity of primary hyperoxaluria type I (PH1) and the fact that in many instances this diagnosis was made without enzymatic and immunohistochemical investigation, other disturbances of oxalate metabolism than those presently known can be expected in PH1. Using a gaschromatographic/mass spectrometric method that allows quantification of these acids, hyperoxaluria and hyperglycoluria was found repeatedly in two unrelated patients. The hyperoxaluria was unresponsive to pyridoxine. There was no nephrocalcinosis or urolithiasis. In the liver biopsy normal AGT activity and normal localization of this enzyme in the peroxisome was found. In one patient abnormal Km and maximal activity and mozaicism of AGT were excluded. Hyperoxaluria and hyperglycoluria were also found in other family members, suggesting autosomal dominant transmission. Although the underlying defect leading to hyperoxaluria and hyperglycoluria could not be identified in these patients, it is probable that they represent a separate type of primary hyperoxaluria.
引用
收藏
页码:1747 / 1752
页数:6
相关论文
共 23 条
[1]   URINARY OXALATE AND GLYCOLATE EXCRETION AND PLASMA OXALATE CONCENTRATION [J].
BARRATT, TM ;
KASIDAS, GP ;
MURDOCH, I ;
ROSE, GA .
ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (04) :501-503
[2]   PRIMARY HYPEROXALURIA TYPE-1 - GENOTYPIC AND PHENOTYPIC HETEROGENEITY [J].
DANPURE, CJ ;
JENNINGS, PR ;
FRYER, P ;
PURDUE, PE ;
ALLSOP, J .
JOURNAL OF INHERITED METABOLIC DISEASE, 1994, 17 (04) :487-499
[3]  
DANPURE CJ, 1995, METABOLIC MOL BASES, P2385
[4]  
DECRAEMER D, 1993, CANCER, V71, P3851, DOI 10.1002/1097-0142(19930615)71:12<3851::AID-CNCR2820711210>3.0.CO
[5]  
2-L
[6]  
DECRAEMER D, 1989, MICRON MICROSC ACTA, V20, P125
[7]   URINARY-EXCRETION OF 2-METHYL-2,3-BUTANEDIOL AND 2,3-PENTANEDIOL IN PATIENTS WITH DISORDERS OF PROPIONATE AND METHYLMALONATE METABOLISM [J].
DURAN, M ;
KETTING, D ;
BRUINVIS, L ;
DORLAND, L ;
WADMAN, SK ;
BAKKEREN, JAJM .
CLINICA CHIMICA ACTA, 1987, 165 (2-3) :197-204
[8]  
ESPEEL M, 1995, DIAGNOSIS HUMAN PERO, P135
[9]   MILD METABOLIC HYPEROXALURIA AND ITS RESPONSE TO PYRIDOXINE [J].
GILL, HS ;
ROSE, GA .
UROLOGIA INTERNATIONALIS, 1986, 41 (05) :393-396
[10]   PRIMARY HYPEROXALURIA TYPE-I - ULTRASTRUCTURAL OBSERVATIONS IN LIVER BIOPSIES [J].
IANCU, TC ;
DANPURE, CJ .
JOURNAL OF INHERITED METABOLIC DISEASE, 1987, 10 (04) :330-338